Technology News and Research

RSS
Thermo Fisher Scientific reinforces ongoing commitment to make advanced technologies more accessible to customers

Thermo Fisher Scientific reinforces ongoing commitment to make advanced technologies more accessible to customers

Fast, new way to rule out potentially dangerous drugs using optogenetics

Fast, new way to rule out potentially dangerous drugs using optogenetics

New interactive radiation therapy planning system can help improve patient's chances of recovery

New interactive radiation therapy planning system can help improve patient's chances of recovery

Researchers agree to test new stem cell gene therapy for Sanfilippo disease in human trial

Researchers agree to test new stem cell gene therapy for Sanfilippo disease in human trial

Innovative technology in NICU can predict risk of major infections in premature or critically ill babies

Innovative technology in NICU can predict risk of major infections in premature or critically ill babies

Graphene flakes can modulate synapses

Graphene flakes can modulate synapses

Titanium dioxide nanoparticles can have low-level effects on oxidative stress genes

Titanium dioxide nanoparticles can have low-level effects on oxidative stress genes

TSRI scientists expanding web services to improve biomedical research

TSRI scientists expanding web services to improve biomedical research

New portable device with hand-held probe could help reduce unnecessary thyroid cancer surgery

New portable device with hand-held probe could help reduce unnecessary thyroid cancer surgery

‘Together we are stronger’ - partnership at the heart of expansion plans to revolutionise medical imaging services

‘Together we are stronger’ - partnership at the heart of expansion plans to revolutionise medical imaging services

Scientists visualize apoptosis in live zebrafish using FLIM OPT method

Scientists visualize apoptosis in live zebrafish using FLIM OPT method

Daiichi buys Japanese rights to CTL’s innovative cardiac regeneration medicine, Heartcel

Daiichi buys Japanese rights to CTL’s innovative cardiac regeneration medicine, Heartcel

EvOx Therapeutics raises £10m to target new therapeutic system for untreatable diseases

EvOx Therapeutics raises £10m to target new therapeutic system for untreatable diseases

Bruker showcases new products, analytical solutions for improved performance at Analytica 2016

Bruker showcases new products, analytical solutions for improved performance at Analytica 2016

Simultaneous DNA, RNA and protein analysis to enhance cancer immunology studies: an interview with Dr Joseph Beechem

Simultaneous DNA, RNA and protein analysis to enhance cancer immunology studies: an interview with Dr Joseph Beechem

Osaka University researchers find way for early detection of AD

Osaka University researchers find way for early detection of AD

Non-invasive 3-D virtual heart assessment tool can help predict arrhythmia risk in patients

Non-invasive 3-D virtual heart assessment tool can help predict arrhythmia risk in patients

Sophisticated technology helps model and simulate optimal dose for pediatric ependymoma patients

Sophisticated technology helps model and simulate optimal dose for pediatric ependymoma patients

Fast image registration technology patent granted in the US

Fast image registration technology patent granted in the US

Pathogen-selective approach to antibiotic development less disruptive to gut microbiome

Pathogen-selective approach to antibiotic development less disruptive to gut microbiome

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.